Our Mission
Puma Biotechnology is a biopharmaceutical company dedicated to the acquisition, development, and commercialization of novel therapeutics for the treatment of cancer.
News Releases
Year
News Releases
- Feb. 12, 2026 - February 12, 2026 - Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results Read
- Feb. 4, 2026 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Read
- Jan. 7, 2026 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Read